Coya Therapeutics, Inc./$COYA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Coya Therapeutics, Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Ticker
$COYA
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
8
ISIN
US22407B1089
Website
COYA Metrics
BasicAdvanced
$98M
-
-$1.08
0.50
-
Price and volume
Market cap
$98M
Beta
0.5
52-week high
$8.29
52-week low
$4.65
Average daily volume
44K
Financial strength
Current ratio
8.84
Quick ratio
8.185
Profitability
EBITDA (TTM)
-19.416
Gross margin (TTM)
-278.32%
Net profit margin (TTM)
-465.00%
Operating margin (TTM)
-527.63%
Effective tax rate (TTM)
4.03%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
-32.06%
Return on equity (TTM)
-52.11%
Valuation
Price to revenue (TTM)
25.089
Price to book
2.93
Price to tangible book (TTM)
2.93
Price to free cash flow (TTM)
-6.058
Free cash flow yield (TTM)
-16.51%
Free cash flow per share (TTM)
-96.57%
Growth
Revenue change (TTM)
-39.87%
Earnings per share change (TTM)
19.41%
3-year earnings per share growth (CAGR)
-20.69%
COYA News
AllArticlesVideos
Coya Therapeutics to Present at the iAccess Alpha Virtual Best Ideas Summer Conference on June 24 – 25, 2025
Business Wire·2 weeks ago
Coya Therapeutics to Participate at the H.C. Wainwright 3rd Annual BioConnect Investor Conference
Business Wire·1 month ago
Coya Therapeutics to Participate in Two Upcoming Conferences in May 2025
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Coya Therapeutics, Inc. stock?
Coya Therapeutics, Inc. (COYA) has a market cap of $98M as of June 30, 2025.
What is the P/E ratio for Coya Therapeutics, Inc. stock?
The price to earnings (P/E) ratio for Coya Therapeutics, Inc. (COYA) stock is 0 as of June 30, 2025.
Does Coya Therapeutics, Inc. stock pay dividends?
No, Coya Therapeutics, Inc. (COYA) stock does not pay dividends to its shareholders as of June 30, 2025.
When is the next Coya Therapeutics, Inc. dividend payment date?
Coya Therapeutics, Inc. (COYA) stock does not pay dividends to its shareholders.
What is the beta indicator for Coya Therapeutics, Inc.?
Coya Therapeutics, Inc. (COYA) has a beta rating of 0.5. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.